AI assistant
Egetis Therapeutics Major Shareholding Notification 2020
3152_iss_2020-11-07_03aba1fd-7e5c-4b77-ad07-85e3f3ad5b55.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Egetis Therapeutics AB (publ)
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktie |
|---|---|
| Before the transaction | |
| Shares | 3,238,427 |
| Voting rights | 3,238,427 |
| Transaction | |
| Reason for major shareholding notification Other | |
| Date | 05/11/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 3,238,427 |
| Directly held voting rights | 3,238,427 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 2.76 % |
| Directly held voting rights | 2.76 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 2.76 % | 3,238,427 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 2.76 % | 3,238,427 |
| Group total holdings |
||
| Voting rights 3,238,427 Percentage of voting rights 2.76 |
||
| Published 07/11/2020 14:19 |
||
| Contact | ||
| Name Jannis Kitsakis |
||
| Phone 070-6038023 Email [email protected] |
||
| CLOSE |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25